Cargando…

A Novel Modality Enables New Evidence-Based Individual Risk Stratification That Can Potentially Lead to Decisive Management and Treatment Decisions in Prostate Cancer

A key step in providing management/treatment options to men with suspected prostate cancer (PCa) is categorizing the risk in terms of the presence of benign, low-risk, intermediate-risk, or high-risk disease. Our novel modality brings new evidence, based on the long-known hallmark characteristic of...

Descripción completa

Detalles Bibliográficos
Autores principales: Weksler, Meir, Simon, Avi, Lenkinski, Robert E., Landsman, Hagar, Matzkin, Haim, Mabjeesh, Nicola, Leibovitch, Ilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914539/
https://www.ncbi.nlm.nih.gov/pubmed/36766529
http://dx.doi.org/10.3390/diagnostics13030424